Therapy News and Research

RSS

ASM to honor LA BioMed investigator for A. baumannii infection study

Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.

14 Sep 2011

A woman's pregnancy outcome can be an indicator of future health conditions

"A woman's pregnancy outcome can be an indicator of future health conditions," stated George R. Saade, M.D., president of the Society for Maternal-Fetal Medicine and professor of obstetrics and gynecology at The University of Texas Medical Branch in Galveston, Texas.

14 Sep 2011

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

Pfizer Oncology announced today that data evaluating crizotinib in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), as well as data from Pfizer's renal cell carcinoma (RCC) portfolio on axitinib, an investigational compound, and SUTENT(sunitinib malate) will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23 - 27, 2011.

14 Sep 2011

Rwanda to treat HIV-positive people in discordant relationships as soon as they test positive

After a landmark study published in May "showed major reductions in HIV transmission among discordant couples due to early treatment," Rwanda has decided to begin treating people in discordant relationships with antiretroviral therapy as soon as they test HIV-positive "as part of a plan to boost national HIV prevention and treatment efforts," PlusNews reports.

14 Sep 2011

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.

14 Sep 2011

Computer models that predict response to treatment

Details of computer models that can predict the chances of a patient responding to their HIV drugs with 80% accuracy are published today in the journal AIDS. The models were developed by the HIV Resistance Response Database Initiative (RDI) using almost half a million pieces of data from approximately 6,000 clinical cases from hundreds of clinics around the world. The models are now available online as part of an experimental treatment support tool, HIV-TRePS.

14 Sep 2011

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.

14 Sep 2011

Mary Ann Liebert launches 'Human Gene Therapy Methods' journal

Mary Ann Liebert, Inc. announces the launch of a journal expansion, Human Gene Therapy Methods, to complement the flagship publication Human Gene Therapy.

14 Sep 2011

VIVUS presents positive results from avanafil phase 3 study in diabetics at 47th EASD meeting

VIVUS, Inc. today presented positive results from the avanafil phase 3 study in diabetics. In the REVIVE-Diabetes study (TA-302), male diabetics receiving avanafil had significant improvement in erectile function.

14 Sep 2011

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.

14 Sep 2011

Rehabilitation the ‘great missing link’ in the healthcare system Leading physicians convene in Brisbane today

The lack of publically funded community-based rehabilitation and restorative programs is one of the great missing links in the Australian health care system, according to leading Australian physicians.

13 Sep 2011

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Bayer HealthCare announced today that the company will present data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

13 Sep 2011

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Researchers from Mount Sinai School of Medicine have for the first time used several imaging techniques to prove the efficacy of a promising new treatment for atherosclerosis—the build-up of plaque in artery walls that can lead to a heart attack.

13 Sep 2011

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans.

13 Sep 2011

Roundup: Ga. rejects rule to curb dental hygienists' work; Ohio high-risk pool faces higher than expected costs

The Georgia Board of Dentistry on Friday rejected a proposed rule that public health officials feared would have restricted dental hygienists' work with low-income patients. Several health groups had said the provision, if approved, would require a dentist to examine a patient before a hygienist can apply sealants, clean teeth and perform other preventive dental services in a public health setting.

13 Sep 2011

Government funding crisis in Swaziland disrupts supply of HIV/AIDS supplies

"An acute government funding crisis in Swaziland, Africa's last absolute monarchy, is disrupting supplies of HIV/AIDS drugs and hampering the fight against the virus in the country with the world's highest infection rate, Medecins Sans Frontieres (MSF) said Friday," Reuters reports.

12 Sep 2011

Low-dose aspirin increases risk for GI bleeding

The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer.

12 Sep 2011

Publix to offer Bioject ZetaJet for flu immunizations

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, announced today that beginning in September 2011, select Publix Super Markets (Publix) in the Southeast region will be offering flu season immunizations utilizing the Bioject ZetaJet™. Publix will be conducting evaluations in 52 stores in Florida, Georgia, Alabama and South Carolina.

12 Sep 2011

Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer

Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.

12 Sep 2011

BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal women

BioSante Pharmaceuticals, Inc., today announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study.

12 Sep 2011

Therapy News and Research

ASM to honor LA BioMed investigator for A. baumannii infection study

A woman's pregnancy outcome can be an indicator of future health conditions

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

Rwanda to treat HIV-positive people in discordant relationships as soon as they test positive

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

Computer models that predict response to treatment

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Mary Ann Liebert launches 'Human Gene Therapy Methods' journal

VIVUS presents positive results from avanafil phase 3 study in diabetics at 47th EASD meeting

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

Rehabilitation the ‘great missing link’ in the healthcare system Leading physicians convene in Brisbane today

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Roundup: Ga. rejects rule to curb dental hygienists' work; Ohio high-risk pool faces higher than expected costs

Government funding crisis in Swaziland disrupts supply of HIV/AIDS supplies

Low-dose aspirin increases risk for GI bleeding

Publix to offer Bioject ZetaJet for flu immunizations

Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer

BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal women

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News